Publication details

Maligní fibrózní histiocytom – rizikové faktory přežití

Title in English MALIGNANT FIBROUS HISTIOCYTOMA – RISK FACTORS OF SURVIVAL
Authors

MAHDAL Michal ROZKYDAL Zbyněk JANÍČEK Pavel

Year of publication 2012
Type Article in Periodical
Magazine / Source Ortopedie
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords soft tissue sarcoma; malignant fibrous histiocytoma
Description Introduction: The purpose of the study was to determine the risk factors influencing the prognosis of malignant fibrous histiocytoma. Material and methods: 43 MFH patients in the mean age of 59 years (18-80) from the period 2001-2008 were included in the study. The mean follow-up was 2.8 years. Results: Thirteen patients (58%) survived 5 years after surgery. 77% of patients survived after wide resection and only 58% after marginal resection. The survival rate was 73% and 43% in patients under 60 years of age at the start of treatment, and in patients over 60 years, respectively, and 100% in patients with surface localisation and only 52% in patients with deep localisation. The survival rate in patients with histological grade I and II was 73%, and 46% in patients with grade III. 79% of patients with the size of the tumour under 8cm in the diameter, and 36% of patients with tumour diameter exceeding 8cm survived. Survival rate in patients with metastasis at the time of the start of treatment was 20%, while in patients without metastasis the survival rate was 63%. Discussion: The authors have found the following risk factors of malignant fibrous histiocytoma survival: age over 60 years, marginal resection, deep localisation, histological grade III, size of the tumour exceeding 8cm, and the presence of metastasis at the time of diagnosis.

You are running an old browser version. We recommend updating your browser to its latest version.

More info